Tuberculosis News and Research

Latest Tuberculosis News and Research

High-dose vitamin D appears to help patients with TB recover more quickly

For decades before antibiotics became generally available, sunshine was used to treat tuberculosis, with patients often being sent to Swiss clinics to soak up the sun's healing rays. Now, for the first time scientists have shown how and why heliotherapy might, indeed, have made a difference.

4 Sep 2012

U.S., Nigeria inaugurate Defense Reference Laboratory in Abuja

U.S. Ambassador to Nigeria Terence McCulley spoke on Monday in Abuja at the inauguration of a Defense Reference Laboratory, Leadership reports, noting he said the laboratory, "which is the first of its kind in the sub-region," was supported by U.S. funding.

1 Sep 2012

Aidspan founder, executive director Bernard Rivers stepping down

The Center for Global Health Policy's "Science Speaks" blog profiles Bernard Rivers, founder and executive director of Aidspan, a watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, who is leaving his position after 10 years.

1 Sep 2012

MDR-TB, XDR-TB more widespread than previously believed, study shows

In a study published on Wednesday in the Lancet, researchers from the Centers for Disease Control and Prevention found that "[a]mong 1,278 patients who were resistant to two or more first-line tuberculosis drugs in Estonia, Latvia, Peru, Philippines, Russia, South Africa, South Korea and Thailand, 43.7 percent showed resistance to at least one second-line drug," which "suggest[s] the deadly disease may become 'virtually untreatable,'" according to the study, Bloomberg Businessweek reports.

31 Aug 2012

Janssen submits bedaquiline MAA with EMA for treatment of multi-drug resistant tuberculosis

Janssen-Cilag International NV (Janssen) today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

31 Aug 2012

Brazil expanding national HIV treatment program to include patients with higher CD4 cell counts

Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.

31 Aug 2012

Drug-resistant tuberculosis levels described as alarming by international study

A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.

30 Aug 2012

India's contribution to global health R&D needs domestic, international support

As the BRIC countries -- Brazil, Russia, India, and China -- invest more in innovations in health technologies and other areas, "many are looking to these countries to correct the global health research and development (R&D) imbalance that leaves the poor without needed products such as an improved tuberculosis (TB) vaccine or tests to help diagnose patients in remote rural settings," David de Ferranti, president of Results for Development Institute (R4D), writes in the Huffington Post Blog.

30 Aug 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 193 of its "Global Fund Observer."

30 Aug 2012

Global Fund Board approves 45 new two-year grants as part of Transitional Funding Mechanism

"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved 45 new two-year grants, from 37 countries, totaling $419.2 million, to fund essential prevention, treatment, and care services provided to the people affected by the three diseases," according to a Global Fund press release.

30 Aug 2012

Sri Lanka succeeds in reducing malaria cases by 99.9% since 1999

Despite nearly three decades of conflict, Sri Lanka has succeeded in reducing malaria cases by 99.9 percent since 1999 and is on track to eliminate the disease entirely by 2014.

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria and Nigeria on Friday "signed two grant agreements ... worth a total of $225 million to support programs that will prevent and treat malaria," a Global Fund press release reports.

29 Aug 2012

Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections

New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacterial infections and the life-threatening complications of chronic inflammation that can result from them.

29 Aug 2012

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help "keep track of whether a patient is taking their medicine on time," Reuters reports.

29 Aug 2012

Global Fund releases funding recommendations for Transitional Funding Mechanism

"The Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released the funding recommendations of its Technical Review Panel for the Transitional Funding Mechanism," the Stop TB Partnership reports in an article on its webpage.

26 Aug 2012

HIV-like immunodeficiency observed in Asia

Researchers have discovered an adult-onset immunodeficiency syndrome with symptoms similar to those of advanced HIV in Thailand and Taiwan.

24 Aug 2012

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Tuberculosis (TB) is second only to HIV/AIDS as the greatest killer worldwide attributable to a single infectious agent, according to the World Health Organization (WHO). With 8.8 million cases in 2010 and 95 percent of TB deaths occurring in low- and middle-income countries, the disease continues to be a major public health problem in the developing world. In a July address to the International Union Against Tuberculosis and Lung Disease, Dartmouth's C. Fordham (Ford) von Reyn shared news of a promising vaccine in the works.

24 Aug 2012

Researcher describes structure and function of tuberculosis efflux pump regulator

Edward Yu took note of the facts - nearly 2 million deaths each year, 9 million infected each year, developments of multidrug-resistant, extensively drug-resistant and now totally drug-resistant strains - and decided to shift his research focus to tuberculosis.

23 Aug 2012

Antibiotics: do they affect contraceptives?

NPS MedicineWise has released information for consumers about taking antibiotics when also using hormonal contraceptives, explaining that there are only two antibiotics that affect how hormonal contraceptives work.

23 Aug 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

High-dose vitamin D appears to help patients with TB recover more quickly

U.S., Nigeria inaugurate Defense Reference Laboratory in Abuja

Aidspan founder, executive director Bernard Rivers stepping down

MDR-TB, XDR-TB more widespread than previously believed, study shows

Janssen submits bedaquiline MAA with EMA for treatment of multi-drug resistant tuberculosis

Brazil expanding national HIV treatment program to include patients with higher CD4 cell counts

Drug-resistant tuberculosis levels described as alarming by international study

India's contribution to global health R&D needs domestic, international support

Aidspan publishes new issue of 'Global Fund Observer'

Global Fund Board approves 45 new two-year grants as part of Transitional Funding Mechanism

Sri Lanka succeeds in reducing malaria cases by 99.9% since 1999

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

Global Fund releases funding recommendations for Transitional Funding Mechanism

HIV-like immunodeficiency observed in Asia

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Researcher describes structure and function of tuberculosis efflux pump regulator

Antibiotics: do they affect contraceptives?

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Tuberculosis News and Research

Latest Tuberculosis News and Research

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in